Novel biomarkers of coronary microvascular disease

被引：8
|
作者：
Hung, Olivia Y. [1 ]
Lee, Suegene K. [2 ]
Eshtehardi, Parham [1 ]
Samady, Habib [1 ]
机构：
[1] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA
来源：
FUTURE CARDIOLOGY | 2016年 / 12卷 / 04期
关键词：
biomarkers; coronary flow reserve; coronary microvascular disease;
D O I：
10.2217/fca-2016-0012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Coronary microvascular disease in the absence of myocardial diseases has traditionally been diagnosed through coronary reactivity testing in the cardiac catheterization laboratory. Compared with invasive procedures, blood-based biomarkers may have reduced cost, less risk of physical harm and greater accessibility, making them ideal for an outpatient management strategy. There are a variety of biomarkers available with potential utility in the management of microvascular disease; however, none have yet been extensively validated or established in this clinical patient population.
引用
收藏
页码：497 / 509
页数：13
相关论文
共 50 条
  • [21] Coronary microvascular dysfunction and inflammation: Insights from the Coronary Microvascular Disease Registry
    Merdler, Ilan
    Chitturi, Kalyan R.
    Chaturvedi, Abhishek
    Li, Jason
    Cellamare, Matteo
    Ozturk, Sevket Tolga
    Sawant, Vaishnavi
    Ben-Dor, Itsik
    Waksman, Ron
    Case, Brian C.
    Hashim, Hayder D.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2024, 69 : 30 - 34
  • [22] Coronary Microvascular Dysfunction and Inflammation: Insights from the Coronary Microvascular Disease Registry
    Merdler, I.
    Case, B. C.
    Li, J.
    Wallace, R.
    Chitturi, K. R.
    Chaturvedi, A.
    Zhang, C.
    Cellamare, M.
    Sawant, V. S.
    Ben-Dor, I.
    Waksman, R.
    Hashim, H. D.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (04) : S48 - S49
  • [23] Plasma Biomarkers of Endothelial Dysfunction and Myocardial Fibrosis in Relation to Measures of Coronary Microvascular Disease in Ischemia With No Obstructive Coronary Arteries
    Shekarestan, Shajan
    Ekenback, Christina
    Jokhaji, Fadi
    Lorstad, Samantha
    Wallen, Hakan
    Tornerud, Mattias
    Ljungman, Petter
    Samad, Bassem
    Linder, Rickard
    Persson, Jonas
    CIRCULATION, 2023, 148
  • [24] Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease
    Zhang, Ping
    Liang, Tao
    Chen, Yao
    Wang, Xuan
    Wu, Tianlong
    Xie, Zhixin
    Luo, Jianfang
    Yu, Yanhong
    Yu, Huimin
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [25] Role of novel biomarkers of inflammation in patients with stable coronary heart disease
    Oren, Huseyin
    Erbay, Ali R.
    Balci, Mustafa
    Cehreli, Sengul
    ANGIOLOGY, 2007, 58 (02) : 148 - 155
  • [26] Novel Inflammatory Biomarkers in Coronary Artery Disease: Potential Therapeutic Approaches
    Voudris, Konstantinos V.
    Chanin, Jake
    Feldman, Dmitriy N.
    Charitakis, Konstantinos
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (22) : 2680 - 2689
  • [27] MICROVASCULAR CHANGES IN CORONARY ARTERY DISEASE
    WELLS, R
    HERMAN, MV
    GORLIN, R
    CIRCULATION, 1966, 34 (4S3) : I237 - &
  • [28] Genetic Insights Into Coronary Microvascular Disease
    Wayne, Nicole
    Singamneni, Venkata S.
    Venkatesh, Rasika
    Cherlin, Tess
    Verma, Shefali S.
    Guerraty, Marie A.
    MICROCIRCULATION, 2025, 32 (01)
  • [29] Definition and epidemiology of coronary microvascular disease
    Conor Bradley
    Colin Berry
    Journal of Nuclear Cardiology, 2022, 29 : 1763 - 1775
  • [30] Definition and epidemiology of coronary microvascular disease
    Bradley, Conor
    Berry, Colin
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (04) : 1763 - 1775
12345